Director/PDMR Shareholding

RNS Number : 9005E
GlaxoSmithKline PLC
15 April 2014
 



                        Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 15 April 2014 of the following increases in their notional interests in Ordinary Shares and American Depositary Shares (ADSs) at a price of 1581.50 pence per Ordinary Share and $53.42 per ADS following the re-investment of dividends paid to shareholders on 10 April 2014.

 

 

Sir Andrew Witty

Acquisition of 2,101 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 2,101 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S Dingemans

Acquisition of 924 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 924 Ordinary Shares under the matching element of the Plan (Company contribution).



Dr M M Slaoui

Acquisition of 791 ADSs under the personal contribution element of the Plan.




Acquisition of 791 ADSs under the matching element of the Plan (Company contribution).



Mr S M Bicknell

Acquisition of 210 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 210 Ordinary Shares under the matching element of the Plan (Company contribution).



Mrs D P Connelly

Acquisition of 153 ADSs under the personal contribution element of the Plan.




Acquisition of 153 ADSs under the matching element of the Plan (Company contribution).



Mr R G Connor

Acquisition of 236 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 236 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr S A Hussain

Acquisition of 119 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 119 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr W C Louv

 

Acquisition of 191 ADSs under the personal contribution element of the Plan.




Acquisition of 191 ADSs under the matching element of the Plan (Company contribution).



Mr D S Redfern

Acquisition of 449 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 449 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms C Thomas 

Acquisition of 338 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 338 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr P C Thomson

Acquisition of 69 Ordinary Shares under the personal contribution element of the Plan.




Acquisition of 69 Ordinary Shares under the matching element of the Plan (Company contribution).



Mr D E Troy

Acquisition of 350 ADSs under the personal contribution element of the Plan.




Acquisition of 350 ADSs under the matching element of the Plan (Company contribution).



Dr P J T Vallance

Acquisition of 986 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 986 Ordinary Shares under the matching element of the Plan (Company contribution).



Ms E Walmsley

Acquisition of 544 Ordinary Shares under the personal contribution element of the Plan.

 


Acquisition of 544 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant measurement period.

 

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

V A Whyte

Company Secretary

15 April 2014

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZELFFZZFXBBE

Companies

GSK (GSK)
UK 100

Latest directors dealings